Fishman Corey N.
Insider CIK 1553594 · MNTA Director · DRTX COO & CFO · ITRM President & CEO, Director · BSTC Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ITRM Iterum Therapeutics plc | M Exercise deriv | 2024-08-06 | 2024-08-12 | 165,226 | — | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | M Exercise deriv | 2024-08-06 | 2024-08-12 | 82,613 | — | $0 | 82,613 | SEC↗ |
| ITRM Iterum Therapeutics plc | M Exercise deriv | 2024-08-06 | 2024-08-12 | 82,613 | — | $0 | 82,613 | SEC↗ |
| ITRM Iterum Therapeutics plc | M Exercise | 2024-08-06 | 2024-08-12 | 82,613 | — | $0 | 137,062 | SEC↗ |
| ITRM Iterum Therapeutics plc | P Buy | 2023-11-20 | 2023-11-20 | 10,000 | $1.59 | $15.9K | 54,449 | SEC↗ |
| ITRM Iterum Therapeutics plc | A Award deriv | 2023-03-31 | 2023-04-03 | 275,000 | — | $0 | 275,000 | SEC↗ |
| ITRM Iterum Therapeutics plc | M Exercise deriv | 2023-03-11 | 2023-03-14 | 14,333 | — | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | A Award | 2023-03-11 | 2023-03-14 | 14,333 | — | $0 | 50,132 | SEC↗ |
| ITRM Iterum Therapeutics plc | F Tax w/h | 2023-03-11 | 2023-03-14 | 5,683 | $0.96 | $5.5K | 44,449 | SEC↗ |
| ITRM Iterum Therapeutics plc | M Exercise deriv | 2022-03-11 | 2022-03-15 | 215,000 | — | $0 | 215,000 | SEC↗ |
| ITRM Iterum Therapeutics plc | M Exercise | 2022-03-11 | 2022-03-15 | 215,000 | — | $0 | 537,008 | SEC↗ |
| ITRM Iterum Therapeutics plc | A Award deriv | 2021-06-23 | 2021-06-25 | 5,280,000 | — | $0 | 5,280,000 | SEC↗ |
| ITRM Iterum Therapeutics plc | A Award deriv | 2021-03-11 | 2021-03-15 | 430,000 | — | $0 | 430,000 | SEC↗ |
| ITRM Iterum Therapeutics plc | S Sale | 2021-01-26 | 2021-01-27 | 85,445 | $1.73 | $147.8K | 322,008 | SEC↗ |
| ITRM Iterum Therapeutics plc | A Award | 2021-01-25 | 2021-01-27 | 167,500 | — | $0 | 407,453 | SEC↗ |
| BSTC BIOSPECIFICS TECHNOLOGIES | D To issuer deriv | 2020-12-02 | 2020-12-02 | 6,000 | $32.87 | $197.2K | 0 | SEC↗ |
| BSTC BIOSPECIFICS TECHNOLOGIES | D To issuer | 2020-12-02 | 2020-12-02 | 2,018 | — | $0 | 0 | SEC↗ |
| BSTC BIOSPECIFICS TECHNOLOGIES | A Award deriv | 2020-05-01 | 2020-05-04 | 6,000 | — | $0 | 6,000 | SEC↗ |
| BSTC BIOSPECIFICS TECHNOLOGIES | A Award | 2020-04-13 | 2020-04-15 | 2,018 | — | $0 | 2,018 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | M Exercise deriv | 2019-06-20 | 2019-06-21 | 4,356 | — | $0 | 0 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | M Exercise | 2019-06-20 | 2019-06-21 | 4,356 | — | $0 | 10,090 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | A Award deriv | 2019-06-19 | 2019-06-21 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ITRM Iterum Therapeutics plc | A Award deriv | 2019-02-15 | 2019-02-19 | 150,000 | — | $0 | 150,000 | SEC↗ |
| ITRM Iterum Therapeutics plc | P Buy | 2018-08-17 | 2018-08-21 | 2,000 | $8.73 | $17.5K | 239,953 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | A Award deriv | 2018-06-20 | 2018-06-25 | 8,855 | — | $0 | 8,855 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | M Exercise deriv | 2018-06-20 | 2018-06-25 | 5,734 | — | $0 | 0 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | A Award deriv | 2018-06-20 | 2018-06-25 | 4,356 | — | $0 | 4,356 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | M Exercise | 2018-06-20 | 2018-06-25 | 5,734 | — | $0 | 5,734 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion deriv | 2018-05-30 | 2018-05-30 | 4,050 | — | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion deriv | 2018-05-30 | 2018-05-30 | 33,259 | — | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion deriv | 2018-05-30 | 2018-05-30 | 1,591 | — | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion | 2018-05-30 | 2018-05-30 | 4,050 | — | $0 | 233,362 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion | 2018-05-30 | 2018-05-30 | 33,259 | — | $0 | 229,312 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion | 2018-05-30 | 2018-05-30 | 1,591 | — | $0 | 234,953 | SEC↗ |
| ITRM Iterum Therapeutics plc | P Buy | 2018-05-30 | 2018-05-30 | 3,000 | $13.00 | $39.0K | 237,953 | SEC↗ |
| ITRM Iterum Therapeutics plc | A Award deriv | 2018-05-24 | 2018-05-29 | 127,307 | — | $0 | 127,307 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | A Award deriv | 2017-06-20 | 2017-06-22 | 5,734 | — | $0 | 5,734 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | A Award deriv | 2017-06-20 | 2017-06-22 | 11,207 | — | $0 | 11,207 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | A Award deriv | 2016-09-22 | 2016-09-26 | 33,000 | — | $0 | 33,000 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | D To issuer deriv | 2014-11-17 | 2014-11-18 | 110,000 | — | $0 | 0 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | D To issuer deriv | 2014-11-17 | 2014-11-18 | 50,000 | — | $0 | 0 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | D To issuer deriv | 2014-11-17 | 2014-11-18 | 12,500 | — | $0 | 0 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | D To issuer deriv | 2014-11-17 | 2014-11-18 | 21,574 | — | $0 | 0 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | D To issuer deriv | 2014-11-17 | 2014-11-18 | 218,750 | — | $0 | 0 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | D To issuer | 2014-11-17 | 2014-11-18 | 24,941 | — | $0 | 0 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | A Award deriv | 2014-05-21 | 2014-05-22 | 110,000 | — | $0 | 412,824 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | A Award deriv | 2013-02-12 | 2013-02-14 | 50,000 | $7.49 | $374.5K | 302,824 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | C Conversion deriv | 2012-07-24 | 2012-07-26 | 179,531 | — | $0 | 0 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | C Conversion | 2012-07-24 | 2012-07-26 | 22,441 | — | $0 | 22,441 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | P Buy deriv | 2012-03-15 | 2012-07-26 | 51,163 | $1.00 | $51.2K | 179,531 | SEC↗ |